Upgrade to SI Premium - Free Trial

'Best-Case Exit Strategy': Biogen (BIIB) Stock Falls as Takeover Rumor Denied, But Analysts Bullish on Takeover Prospect

December 30, 2021 8:07 AM
Biogen (NASDAQ: BIIB) stock price is down over 6.5% in pre-open Thursday after Samsung Group denied it is engaged in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments Mergers and Acquisitions

Next Articles